These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1529931)

  • 1. Mechanisms of action and efficacy of nitrates in heart failure.
    Cohn JN
    Am J Cardiol; 1992 Sep; 70(8):88B-92B. PubMed ID: 1529931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitrates in congestive heart failure.
    Dupuis J
    Cardiovasc Drugs Ther; 1994 Jun; 8(3):501-7. PubMed ID: 7947367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
    Elkayam U; Bitar F
    Am J Cardiol; 2005 Oct; 96(7B):37i-43i. PubMed ID: 16226934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cardiac failure and nitrates].
    Galinier M; Bounhoure JP
    Ann Cardiol Angeiol (Paris); 1997; 46(7):415-9. PubMed ID: 9452775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outpatient vasodilator therapy of congestive heart failure. Consideration of agents at rest and during exercise.
    Chatterjee K; Massie B; Rubin S; Gelberg H; Brundage BH; Ports TA
    Am J Med; 1978 Jul; 65(1):134-45. PubMed ID: 99031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of organic nitrates in the treatment of heart failure.
    Elkayam U; Karaalp IS; Wani OR; Tummala P; Akhter MW
    Prog Cardiovasc Dis; 1999; 41(4):255-64. PubMed ID: 10362348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.
    Massie B; Chatterjee K; Werner J; Greenberg B; Hart R; Parmley WW
    Am J Cardiol; 1977 Nov; 40(5):794-801. PubMed ID: 411364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrates versus angiotensin-converting enzyme inhibitors for congestive heart failure.
    Cohn JN
    Am J Cardiol; 1993 Sep; 72(8):21C-24C; discussion 24C-26C. PubMed ID: 8372797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New perspectives on therapeutic application of nitrates as vasodilator agents for severe chronic heart failure.
    Packer M
    Am J Med; 1983 Jun; 74(6B):61-72. PubMed ID: 6859073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitrates in heart failure.
    Elkayam U
    Cardiol Clin; 1994 Feb; 12(1):73-85. PubMed ID: 8181027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrates in heart failure. Pathophysiological mechanisms and therapeutic applications.
    Timmis AD; Richardson PJ
    Scand J Clin Lab Invest Suppl; 1984; 173():59-64. PubMed ID: 6442003
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nitrates in the treatment of heart failure].
    Dirschinger J; Hall D; Rudolph W
    Herz; 1990 Jun; 15(3):171-8. PubMed ID: 2115855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Zamani P; Akers S; Soto-Calderon H; Beraun M; Koppula MR; Varakantam S; Rawat D; Shiva-Kumar P; Haines PG; Chittams J; Townsend RR; Witschey WR; Segers P; Chirinos JA
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28219917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrates for congestive heart failure.
    Cohn JN
    Am J Cardiol; 1985 Jul; 56(2):19A-23A. PubMed ID: 4014049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrates in the treatment of congestive heart failure.
    Elkayam U
    Am J Cardiol; 1996 May; 77(13):41C-51C. PubMed ID: 8638526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasodilator treatment with isosorbide dinitrate and hydralazine in chronic heart failure.
    Massie BM; Kramer B; Shen E; Haughom F
    Br Heart J; 1981 Apr; 45(4):376-84. PubMed ID: 7225252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survey of the use of organic nitrates for the treatment of chronic congestive heart failure in the United States.
    Bitar F; Akhter MW; Khan S; Singh H; Elkayam U
    Am J Cardiol; 2004 Dec; 94(11):1465-8. PubMed ID: 15566930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril.
    Mehra A; Ostrzega E; Shotan A; Johnson JV; Elkayam U
    Am J Cardiol; 1992 Nov; 70(15):1310-4. PubMed ID: 1442583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.